Nasdaq Will Delist Insys Stock Due To Voluntary Bankruptcy Filing
NEW YORK — The Nasdaq Stock Market on June 10 told Insys Therapeutics Inc. that because of its bankruptcy petition the day before, it will be delisted from the over-the-counter stock...To view the full article, register now.
Already a subscriber? Click here to view full article